# Patent

## Title
Derivatives of phenylpropenylamine

## Abstract

The ingredients are screened, mixed and filled into a hard gelatin capsule.

## Background
## Claims

1. A pharmaceutical composition having H-1 and H-2 histamine receptor inhibiting activity which comprises about 30 mg. to about 250 mg. of an antihistamine, said antihistamine being a compound which inhibits those histamine receptors inhibited by mepyramine, about 50 mg. to about 500 mg. of an H-2 histamine receptor inhibitor, H-2 histamine receptors being those histamine receptors which are not inhibited by mepyramine but are inhibited by burimamide, and a pharmaceutically acceptable diluent or carrier, wherein said H-2 histamine receptor inhibitor is a compound of the formula: ##STR15## wherein A is such that there is formed together with the carbon atom shown a thiazole, isothiazole or pyridine ring; X.sub.1 is hydrogen, lower alkyl, halogen, amino or hydroxyl; X.sub.2 is hydrogen; k is 1; m is 2; Y is sulphur; E is NR.sub.2 ; R.sub.1 is hydrogen or lower alkyl; and R.sub.2 is hydrogen, nitro or cyano, or a pharmaceutically acceptable acid addition salt thereof.

2. A pharmaceutical composition according to claim 1 wherein the antihistamine is a compound selected from the group consisting of mepyramine, mebrophenhydramine, promethazine, diphenhydramine, chlorpheniramine, triprolidene, antazoline, bromodiphenydramine, parabromodylamine, carbinoxamine, cyproheptadine, chlorcyclizine, dimethindene, diphenylpyraline, dimethothiazine, methdilazine, trimeprazine, mebhydroline, methapyrilene, phenindamine, pheniramine, phenyltoloxamine and pyrrobutamine.

3. A method of inhibiting H-1 and H-2 histamine receptors which comprises administering to an animal in need thereof, in amounts sufficient to inhibit both H-1 and H-2 histamine receptors, an antihistamine, said antihistamine being a compound which inhibits those histamine receptors inhibited by mepyramine, and an H-2 histamine receptor inhibitor, said H-1 histamine receptors being those histamine receptors which are inhibited by mepyramine and said H-2 histamine receptors being those histamine receptors which are not inhibited by mepyramine but are inhibited by burimamide, wherein said H-2 histamine receptor inhibitor is a compound of the formula: ##STR16## wherein A is such that there is formed together with the carbon atom shown a thiazole, isothiazole or pyridine ring; X.sub.1 is hydrogen, lower alkyl, halogen, amino or hydroxyl; X.sub.2 is hydrogen, k is 1; m is 2; Y is sulphur; E is NR.sub.2 ; R.sub.1 is hydrogen or lower alkyl; and R.sub.2 is hydrogen, nitro or cyano, or a pharmaceutically acceptable acid addition salt thereof.

4. A method of claim 3 wherein the antihistamine is a compound selected from the group consisting of mepyramine, mebrophenhydramine, promethazine, diphenhydramine, chlorpheniramine, triprolidene, antazoline, bromodiphenydramine, parabromdylamine, carbinoxamine, cyproheptadine, chlorcyclizine, dimethindene, diphenylpyraline, dimethothiazine, methdilazine, trimeprazine, mebhydroline, methapyrilene, phenindamine, pheniramine, phenyltoloxamine and pyrrobutamine.

5. A method of producing anti-inflammatory activity which comprises administering to an animal in need thereof, in amounts sufficient to produce said activity, an antihistamine, said antihistamine being a compound which inhibits those histamine receptors inhibited by mepyramine, and an H-2 histamine receptor inhibitor, said H-2 histamine receptors being those histamine receptors which are not inhibited by mepyramine but are inhibited by burimamide, wherein said H-2 histamine receptor inhibitor is a compound of the formula: ##STR17## wherein A is such that there is formed together with the carbon atom shown a thiazole, isothiazole or pyridine ring; X.sub.1 is hydrogen, lower alkyl, halogen, amino or hydroxyl; X.sub.2 is hydrogen; k is 1; m is 2; Y is sulphur; E is NR.sub.2 ; R.sub.1 is hydrogen or lower alkyl; and R.sub.2 is hydrogen, nitro or cyano, or a pharmaceutically acceptable acid addition salt thereof.

6. A method of claim 5 in which the antihistamine is a compound selected from the group consisting of mepyramine, mebrophenhydramine, promethazine, diphenhydramine, chlorpheniramine, triprolidene, antazoline, bromodiphenhydramine, parabromdylamine, carbinoxamine, cyproheptadine, chlorcyclizine, dimethindene, diphenylpyraline, dimethothiazine, methdilazine, trimeprazine, mebhydroline, methapyrilene, phenindamine, pheniramine, phenyltoloxamine and pyrrobutamine.